Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) - Total Assets

Latest as of December 2025: €457.93 Million EUR ≈ $535.36 Million USD

Based on the latest financial reports, Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) holds total assets worth €457.93 Million EUR (≈ $535.36 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See EUZ total equity for net asset value and shareholders' equity analysis.

Eckert & Ziegler Strahlen- und Medizintechnik AG - Total Assets Trend (2013–2025)

This chart illustrates how Eckert & Ziegler Strahlen- und Medizintechnik AG's total assets have evolved over time, based on quarterly financial data.

Eckert & Ziegler Strahlen- und Medizintechnik AG - Asset Composition Analysis

Current Asset Composition (December 2025)

Eckert & Ziegler Strahlen- und Medizintechnik AG's total assets of €457.93 Million consist of 54.2% current assets and 45.9% non-current assets.

Asset Category Amount (EUR) % of Total Assets
Cash & Equivalents €0.00 28.1%
Accounts Receivable €44.96 Million 9.8%
Inventory €45.97 Million 10.0%
Property, Plant & Equipment €0.00 0.0%
Intangible Assets €11.11 Million 2.4%
Goodwill €34.58 Million 7.6%

Asset Composition Trend (2013–2025)

This chart illustrates how Eckert & Ziegler Strahlen- und Medizintechnik AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Eckert & Ziegler Strahlen- und Medizinte market cap and net worth.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Eckert & Ziegler Strahlen- und Medizintechnik AG's current assets represent 54.2% of total assets in 2025, an increase from 40.7% in 2013.
  • Cash Position: Cash and equivalents constituted 28.1% of total assets in 2025, up from 16.5% in 2013.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, a decrease from 28.0% in 2013.
  • Asset Diversification: The largest asset category is inventory at 10.0% of total assets.

Eckert & Ziegler Strahlen- und Medizintechnik AG Competitors by Total Assets

Key competitors of Eckert & Ziegler Strahlen- und Medizintechnik AG based on total assets are shown below.

Company Country Total Assets
INKON Life Technology Co Ltd
SHE:300143
China CN¥4.15 Billion
CareRay Digital Medical Technology Co Ltd
SHG:688607
China CN¥988.48 Million
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS
USA $139.92 Million
Universus Photo Imagings Limited
NSE:UNIVPHOTO
India Rs8.57 Billion
HansBiomed Corporation
KQ:042520
Korea ₩126.41 Billion
Aligned Genetics Inc
KQ:238120
Korea ₩45.11 Billion
Heramed Ltd
AU:HMD
Australia AU$1.04 Million
Acarix A/S
ST:ACARIX
Sweden Skr48.33 Million

Eckert & Ziegler Strahlen- und Medizintechnik AG - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 3.45 3.12 3.85
Quick Ratio 2.81 2.51 3.05
Cash Ratio 0.00 0.00 0.00
Working Capital €176.18 Million €153.15 Million €132.57 Million

Eckert & Ziegler Strahlen- und Medizintechnik AG - Advanced Valuation Insights

This section examines the relationship between Eckert & Ziegler Strahlen- und Medizintechnik AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 3.66
Latest Market Cap to Assets Ratio 1.98
Asset Growth Rate (YoY) 3.5%
Total Assets €457.93 Million
Market Capitalization $905.45 Million USD

Valuation Analysis

Above Book Valuation: The market values Eckert & Ziegler Strahlen- und Medizintechnik AG's assets above their book value (1.98x), reflecting positive investor sentiment about the company's future prospects.

Positive Asset Growth: Eckert & Ziegler Strahlen- und Medizintechnik AG's assets grew by 3.5% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Eckert & Ziegler Strahlen- und Medizintechnik AG (2013–2025)

The table below shows the annual total assets of Eckert & Ziegler Strahlen- und Medizintechnik AG from 2013 to 2025.

Year Total Assets Change
2025-12-31 €457.93 Million
≈ $535.36 Million
+3.51%
2024-12-31 €442.40 Million
≈ $517.21 Million
+0.69%
2023-12-31 €439.36 Million
≈ $513.66 Million
+5.40%
2022-12-31 €416.84 Million
≈ $487.33 Million
+19.87%
2021-12-31 €347.73 Million
≈ $406.53 Million
+19.08%
2020-12-31 €292.00 Million
≈ $341.38 Million
+6.48%
2019-12-31 €274.24 Million
≈ $320.61 Million
+19.73%
2018-12-31 €229.05 Million
≈ $267.78 Million
+5.56%
2017-12-31 €216.99 Million
≈ $253.68 Million
+8.78%
2016-12-31 €199.47 Million
≈ $233.20 Million
+1.42%
2015-12-31 €196.68 Million
≈ $229.93 Million
+4.99%
2014-12-31 €187.33 Million
≈ $219.01 Million
+5.00%
2013-12-31 €178.41 Million
≈ $208.58 Million
--

About Eckert & Ziegler Strahlen- und Medizintechnik AG

F:EUZ Germany Medical Devices
Market Cap
$1.08 Billion
€927.35 Million EUR
Market Cap Rank
#9557 Global
#1164 in Germany
Share Price
€14.82
Change (1 day)
-0.80%
52-Week Range
€13.90 - €68.45
All Time High
€133.02
About

Eckert & Ziegler SE manufactures and sells isotope technology components worldwide. It operates through two segments, Medical and Isotope Products. The company provides small implants for the treatment of prostate cancer seeds; and eye applicators based on ruthenium-106 and iodine-125 for the treatment of uveal melanomas; brain seed, HDR and brachytherapy; therapeutic and radiotherapy accessories… Read more